Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone densitometry as an adjunct to GnRH agonist therapy

C E Cann1

  • 1Department of Radiology, University of California, San Francisco, USA.

The Journal of Reproductive Medicine
|June 6, 1998
PubMed
Summary

Gonadotropin releasing hormone (GnRH) agonist therapy can cause temporary bone density loss in women. Careful monitoring with bone densitometry, especially spinal measurements, is recommended for those with low baseline bone density to prevent fracture risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. 1982.

Clinical orthopaedics and related research·2000
Same author

A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses.

The American journal of clinical nutrition·1998
Same author

Skeletal development in newborn and weanling northern elephant seals.

The American journal of physiology·1994
Same author

Oral bone imaging: the role of newer techniques.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·1993
Same author

Comparison of xenon-enhanced CT with ultrafast CT for measurement of regional cerebral blood flow.

AJNR. American journal of neuroradiology·1993
Same author

Clinical use of QCT continues CT revolution.

Diagnostic imaging·1993

Area of Science:

  • Endocrinology
  • Bone Physiology
  • Medical Imaging

Background:

  • Gonadotropin releasing hormone (GnRH) agonists are used to treat conditions like endometriosis.
  • GnRH agonist therapy can lead to estrogen deficiency, impacting bone health.
  • Bone densitometry use during clinical trials has yielded varied conclusions regarding skeletal effects.

Purpose of the Study:

  • To establish optimal bone densitometry protocols for women undergoing GnRH agonist therapy.
  • To provide guidance on when and how to use bone densitometry methods.
  • To ensure proper interpretation of bone density results in this patient population.

Main Methods:

  • Literature review of bone densitometry studies in women on GnRH agonists.
  • Analysis considering bone physiology and different densitometry device measurements.
Keywords:
Non-programmatic

Related Experiment Videos

  • Development of a framework for patient assessment and monitoring.

    • Main Results:

    • Most women on GnRH agonists experience transient bone density decrease due to estrogen deficiency.
    • Bone density is typically regained after treatment cessation, though recovery may take years.
    • Women with pre-existing low bone density are at higher risk of fracture and require careful monitoring.

    Conclusions:

    • Bone densitometry methods provide different information and require proper interpretation.
    • Peripheral bone measurements can assess baseline status, but spinal measurements are crucial for monitoring GnRH agonist effects.
    • Spinal bone densitometry offers sufficient sensitivity to track skeletal changes during and after GnRH agonist therapy.